FGFR1 is an adverse outcome indicator for luminal A breast cancers

Fibroblast growth factor receptor 1 (FGFR1) has been suggested to be the candidate gene for 8p11–12 amplification in breast cancer and its therapeutic/prognostic value is explored. Most previous studies focused on FGFR1 gene amplification, which may not necessarily lead to protein expression. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yu-Jie, Tsang, Julia Y.S., Ni, Yun-Bi, Chan, Siu-Ki, Chan, Kui-Fat, Tse, Gary M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826266/
https://www.ncbi.nlm.nih.gov/pubmed/26673008
http://dx.doi.org/10.18632/oncotarget.6563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826266/
https://www.ncbi.nlm.nih.gov/pubmed/26673008
http://dx.doi.org/10.18632/oncotarget.6563

Ejemplares similares